TABLE 4.
Severity of rejectiona
| Tacrolimus/prednisone | Tacrolimus/ prednisone/MMF |
|
|---|---|---|
| Borderline | 5 (11%) | 5 (19%) |
| Banff | ||
| 1A | 16 (36%) | 11 (41%) |
| 1B | 4 (9%) | 4 (15%) |
| Banff 2 | 19 (43%) | 7 (26%) |
| No biopsy | 3 | 1 |
Percentages are calculated within groups.
Severity of rejectiona
| Tacrolimus/prednisone | Tacrolimus/ prednisone/MMF |
|
|---|---|---|
| Borderline | 5 (11%) | 5 (19%) |
| Banff | ||
| 1A | 16 (36%) | 11 (41%) |
| 1B | 4 (9%) | 4 (15%) |
| Banff 2 | 19 (43%) | 7 (26%) |
| No biopsy | 3 | 1 |
Percentages are calculated within groups.